BioCentury
ARTICLE | Company News

OcellO, Merus in cancer antibodies screening deal

January 16, 2013 2:28 AM UTC

OcellO B.V. (Leiden, the Netherlands) partnered with Merus B.V. (Utrecht, the Netherlands) to screen human bispecific antibodies from Merus -- called Biclonics -- for cancer. OcellO will use its 3-D c...